Clinical Trials Browser

Phase 3 × Completed × Herpes Zoster × Clear all

NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

Phase 3 Completed

237 enrolled 20 charts

Herpes Zoster

NCT01254630 2019-09-30

V212-011

Phase 3 Completed

5,305 enrolled 20 charts

Other hematologic neoplasm

Herpes Zoster, Hematologic Neoplasms

NCT01767467 2018-06-06

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

Phase 3 Completed

568 enrolled 26 charts

Herpes Zoster